Reduction of PKCβII activity in smooth muscle cells attenuates acute arterial injury

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 123-130

  Huang, Chun ^a   Chang, Jong Sun ^a   Xu, Yunlu ^a   Li, Qing ^a   Zou, Yu Shan ^a   Yan, Shi Fang ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Arterial injury; Mutant PKC II; Signal transduction; SMC; Transgenic mouse

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA II; TRANSGELIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; EGR1 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE; MUSCLE PROTEIN; PROTEIN KINASE C;

ACUTE ARTERIAL INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DELETION MUTANT; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMORAL ARTERY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTIMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE; ANIMAL; CELL LINE; CELL MOTION; CELL PROLIFERATION; DISEASE MODEL; DOWN REGULATION; ENDOTHELIUM CELL; ENZYMOLOGY; GENETICS; INJURY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; STENOSIS, OCCLUSION AND OBSTRUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EARLY GROWTH RESPONSE PROTEIN 1; ENDOTHELIAL CELLS; FEMORAL ARTERY; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA;

EID: 77956229497     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.05.039     Document Type: Article

References (29)

1. Abedi H., Zachary I. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res 1995, 30:544-556.
2. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995, 75:487-517.
3. Schwartz S.M., Heimark R.L., Majesky M.W. Developmental mechanisms underlying pathology of arteries. Physiol Rev 1990, 70:1177-1209.
4. Cho A., Reidy M.A. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 2002, 91:845-851.
5. Galis Z.S., Johnson C., Godin D., et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002, 91:852-859.
6. Andrassy M., Belov D., Harja E., et al. Central role of PKCbeta in neointimal expansion triggered by acute arterial injury. Circ Res 2005, 96:476-483.
7. Li L., Miano J.M., Mercer B., Olson E.N. Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 1996, 132:849-859.
8. Sakaguchi T., Yan S.F., Yan S.D., et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 2003, 111:959-972.
9. Roque M., Fallon J.T., Badimon J.J., et al. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol 2000, 20:335-342.
10. Tang Y.M., Ashendel C.L. Isolation of cloned mouse protein kinase C beta-II cDNA and its sequence. Nucleic Acids Res 1990, 18:5310.
11. Chalfant C.E., Ohno S., Konno Y., et al. A carboxy-terminal deletion mutant of protein kinase C beta II inhibits insulin-stimulated 2-deoxyglucose uptake in L6 rat skeletal muscle cells. Mol Endocrinol 1996, 10:1273-1281.
12. Lee S.L., Wang Y., Milbrandt J. Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transplantation factor NGFI-A (EGR1). Mol Cell Biol 1996, 16:4566-4572.
13. Leitges M., Schmedt C., Guinamard R., et al. Immunodeficiency in protein kinase Cß deficient mice. Science 1996, 273:788-791.
14. Gallo R., Padurean A., Toschi V., et al. Prolonged thrombin inhibitor reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation 1998, 97:581-588.
15. Travo P., Barrett G., Burnstock G. Differences in proliferation of primary cultures of vascular smooth muscle cells taken from male and female rats. Blood Vessels 1980, 17:110-116.
16. Kobayashi M., Inoue K., Warabi E., Minutesami T., Kodama T. A simple method of isolating mouse aortic endothelial cells. J Atheroscler Thromb 2004, 12:138-142.
17. Harja E., Bucciarelli L.G., Lu Y., et al. Early growth response-1 promotes atherogenosis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Circ Res 2004, 94:333-339.
18. Jovinge S., Hultgardh-Nilsson A., Regnstrom J., Nilsson J. Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 1997, 17:490-497.
19. Moon S.K., Cho G.O., Jung S.Y., et al. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun 2003, 301:1069-1078.
20. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 1983, 49:327-333.
21. Yan S.F., Lu J., Zou Y.S., et al. Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem 1999, 274:15030-15040.
22. Leitges M., Mayr M., Braun U., et al. Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice. J Clin Invest 2001, 108:1505-1512.
23. Cho S.J., Kang M.J., Homer R.J., et al. Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling. J Biol Chem 2006, 281:8161-8168.
24. Avdi N.J., Winston B.W., Russel M., et al. Activation of MEKK by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Mapping pathways for mitogen-activated protein kinase activation. J Biol Chem 1996, 271:33598-33606.
25. Grammer T.C., Blenis J. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases. Oncogene 1997, 14:1635-1642.
26. Wei S., Liu J.H., Epling-Burnette P.K., et al. IL-2 induces the association of IL-2Rbeta, lyn, and MAP kinase ERK-1 in human neutrophils. Immunobiology 2000, 202:363-382.
27. Crossthwaite A.J., Valli H., Williams R.J. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones. J Neurochem 2004, 88:1127-1139.
28. Fujita T., Asai T., Andrassy M., et al. PKCbeta regulates ischemia/reperfusion injury in the lung. J Clin Invest 2004, 113:1615-1623.
29. Yan S.F., Lu J., Zou Y.S., et al. Protein kinase C-beta and oxygen deprivation. A novel Egr-1 dependent pathway for fibrin deposition in hypoxemic vasculature. J Biol Chem 2000, 275:11921-11928.